Moreover, in vivo evidence from NFATc1nuc transgenic mice and Akita mice showed NFAT activation-induced podocyte apoptosis and injury, and NFAT-dependent TRPC6 expression, the mutations of which have been shown to be associated with proteinuria and glomerulosclerosis in human patients. Here, TRPC6 is linked to glomerulosclerosis.